What kind of pharma is valued by people? Weight loss drug maker and not cancer drug makers.

  • Summary
  • Companies
  • Biden proposes expanding coverage for anti-obesity drugs
  • Novo shares jump as much as 4.9%, Lilly stock also gains
  • Amgen weight-loss drug trial results miss market expectations
Nov 26 (Reuters) - Shares of weight-loss drugmakers Novo Nordisk and Eli Lilly rose on Tuesday after U.S. President Joe Biden proposed expanding coverage of anti-obesity drugs under state-run health plans and as a potential rival drug missed expectations in a trial.
Under the proposal, out-of-pocket expenses for the drugs would be reduced for millions of Americans on Medicare and Medicaid, for some by as much as 95%.
 
So people value big tech for social media entertainment and big pharma for anti obesity drugs for last one year. Who cares and value cancer drug development? Nobody. Only Kpkb big pharma when they get cancer but never value never give benefits to big pharma stocks for cancer development.
 
Back
Top